Omrix Biopharmaceuticals, part of Johnson & Johnson, develops and manufactures plasma-derived biosurgical products such as fibrin sealants and haemostats used in surgery.
Distributor: Johnson & Johnson S.A., Spain
No comments available.
Leave your rating & comment